Ahmed K. Toma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ahmed K. Toma has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Louise Craven
Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK
3 shared publications - Selma Al-Ahmad
Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK
2 shared publications - Ugan Reddy
Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK
2 shared publications - Aleksandra Sobieraj
Department of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom
1 shared publication - Alexandra Valetopoulou
Wellcome/EPSRC Centre for Interventional and Surgical Sciences, University College London, London, UK
1 shared publication - Anand S. Pandit
Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK
1 shared publication
Latest Publications
- Open Access
- 16 April 2024
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 166 (1) , 1-7
Chemical angioplasty vs. balloon plus chemical angioplasty for delayed cerebral ischemia: a pilot study of PbtO2 outcomes
Background: Delayed cerebral ischaemia (DCI) is a major cause of morbidity and mortality after aneurysmal subarachnoid haemorrhage (aSAH). Chemical angioplasty (CA) and transluminal balloon angioplasty (TBA) are used to treat patients with refractory vasospasm causing DCI. Multi-modal monitoring including brain tissue oxygenation (PbtO2) is routinely used at this centre for early detection and management of DCI following aSAH. In this single-centre pilot study, we are comparing these two treatment modalities and their effects on PbtO2. Methods: Retrospective case series of patients with DCI who had PbtO2 monitoring as part of their multimodality monitoring and underwent either CA or TBA combined with CA. PbtO2 values were recorded from intra-parenchymal Raumedic NEUROVENT-PTO® probes. Data were continuously collected and downloaded as second-by-second data. Comparisons were made between pre-angioplasty PbtO2 and post-angioplasty PbtO2 median values (4 h before angioplasty, 4 h after and 12 h after). Results: There were immediate significant improvements in PbtO2 at the start of intervention in both groups. PbtO2 then increased by 13 mmHg in the CA group and 15 mmHg in the TBA plus CA group in the first 4 h post-intervention. This improvement in PbtO2 was sustained for the TBA plus CA group but not the CA group. Conclusion: Combined balloon plus chemical angioplasty results in more sustained improvement in brain tissue oxygenation compared with chemical angioplasty alone. Our findings suggest that PbtO2 is a useful tool for monitoring the response to angioplasty in vasospasm.
- 16 April 2024
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 166 (1) , 1-7
Open AccessChemical angioplasty vs. balloon plus chemical angioplasty for delayed cerebral ischemia: a pilot study of PbtO2 outcomes
Background: Delayed cerebral ischaemia (DCI) is a major cause of morbidity and mortality after aneurysmal subarachnoid haemorrhage (aSAH). Chemical angioplasty (CA) and transluminal balloon angioplasty (TBA) are used to treat patients with refractory vasospasm causing DCI. Multi-modal monitoring including brain tissue oxygenation (PbtO2) is routinely used at this centre for early detection and management of DCI following aSAH. In this single-centre pilot study, we are comparing these two treatment modalities and their effects on PbtO2. Methods: Retrospective case series of patients with DCI who had PbtO2 monitoring as part of their multimodality monitoring and underwent either CA or TBA combined with CA. PbtO2 values were recorded from intra-parenchymal Raumedic NEUROVENT-PTO® probes. Data were continuously collected and downloaded as second-by-second data. Comparisons were made between pre-angioplasty PbtO2 and post-angioplasty PbtO2 median values (4 h before angioplasty, 4 h after and 12 h after). Results: There were immediate significant improvements in PbtO2 at the start of intervention in both groups. PbtO2 then increased by 13 mmHg in the CA group and 15 mmHg in the TBA plus CA group in the first 4 h post-intervention. This improvement in PbtO2 was sustained for the TBA plus CA group but not the CA group. Conclusion: Combined balloon plus chemical angioplasty results in more sustained improvement in brain tissue oxygenation compared with chemical angioplasty alone. Our findings suggest that PbtO2 is a useful tool for monitoring the response to angioplasty in vasospasm.
- 20 January 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 226, 107608
Effect of CPR in maintaining brain tissue oxygen (PbtO2) during a cardiac arrest
- 20 January 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 226, 107608
Effect of CPR in maintaining brain tissue oxygen (PbtO2) during a cardiac arrest
- Open Access
- 20 January 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 22
Predicting neurosurgical referral outcomes in patients with chronic subdural hematomas using machine learning algorithms – A multi-center feasibility study
Background: Chronic subdural hematoma (CSDH) incidence and referral rates to neurosurgery are increasing. Accurate and automated evidence-based referral decision-support tools that can triage referrals are required. Our objective was to explore the feasibility of machine learning (ML) algorithms in predicting the outcome of a CSDH referral made to neurosurgery and to examine their reliability on external validation. Methods: Multicenter retrospective case series conducted from 2015 to 2020, analyzing all CSDH patient referrals at two neurosurgical centers in the United Kingdom. 10 independent predictor variables were analyzed to predict the binary outcome of either accepting (for surgical treatment) or rejecting the CSDH referral with the aim of conservative management. 5 ML algorithms were developed and externally tested to determine the most reliable model for deployment. Results: 1500 referrals in the internal cohort were analyzed, with 70% being rejected referrals. On a holdout set of 450 patients, the artificial neural network demonstrated an accuracy of 96.222% (94.444–97.778), an area under the receiver operating curve (AUC) of 0.951 (0.927–0.973) and a brier score loss of 0.037 (0.022–0.056). On a 1713 external validation patient cohort, the model demonstrated an AUC of 0.896 (0.878–0.912) and an accuracy of 92.294% (90.952–93.520). This model is publicly deployed: https://medmlanalytics.com/neural-analysis-model/. Conclusion: ML models can accurately predict referral outcomes and can potentially be used in clinical practice as CSDH referral decision making support tools. The growing demand in healthcare, combined with increasing digitization of health records raises the opportunity for ML algorithms to be used for decision making in complex clinical scenarios.
- 20 January 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 22
Open AccessPredicting neurosurgical referral outcomes in patients with chronic subdural hematomas using machine learning algorithms – A multi-center feasibility study
Background: Chronic subdural hematoma (CSDH) incidence and referral rates to neurosurgery are increasing. Accurate and automated evidence-based referral decision-support tools that can triage referrals are required. Our objective was to explore the feasibility of machine learning (ML) algorithms in predicting the outcome of a CSDH referral made to neurosurgery and to examine their reliability on external validation. Methods: Multicenter retrospective case series conducted from 2015 to 2020, analyzing all CSDH patient referrals at two neurosurgical centers in the United Kingdom. 10 independent predictor variables were analyzed to predict the binary outcome of either accepting (for surgical treatment) or rejecting the CSDH referral with the aim of conservative management. 5 ML algorithms were developed and externally tested to determine the most reliable model for deployment. Results: 1500 referrals in the internal cohort were analyzed, with 70% being rejected referrals. On a holdout set of 450 patients, the artificial neural network demonstrated an accuracy of 96.222% (94.444–97.778), an area under the receiver operating curve (AUC) of 0.951 (0.927–0.973) and a brier score loss of 0.037 (0.022–0.056). On a 1713 external validation patient cohort, the model demonstrated an AUC of 0.896 (0.878–0.912) and an accuracy of 92.294% (90.952–93.520). This model is publicly deployed: https://medmlanalytics.com/neural-analysis-model/. Conclusion: ML models can accurately predict referral outcomes and can potentially be used in clinical practice as CSDH referral decision making support tools. The growing demand in healthcare, combined with increasing digitization of health records raises the opportunity for ML algorithms to be used for decision making in complex clinical scenarios.
- 1 June 2020
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 76, 15-19
Interpretation of lumbar cerebrospinal fluid leukocytosis after cranial surgery: The relevance of aseptic meningitis
- 1 June 2020
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 76, 15-19
Interpretation of lumbar cerebrospinal fluid leukocytosis after cranial surgery: The relevance of aseptic meningitis